AgenT

Improve your clinical success rate Test your molecules on a disruptive model faithfully mimicking progression of Alzheimer’s disease 99% of clinical trials for Alzheimer’s disease (AD) mainly fail because current mouse models do not fully recapitulate the human AD course. After long years of intensive research, AgenT collaborators have developed the most suitable mouse and rat models to date to study the pre-clinical phase of AD and enable the development of drugs to counteract the progression of this disease. AgenT offers you an extensive and detailed pre-clinical characterization of your promising candidate compounds.